Limmatech Biologics Ag
Clinical trials sponsored by Limmatech Biologics Ag, explained in plain language.
-
New vaccine aims to protect babies from severe diarrhea
⭐️ VACCINE ⭐️ CompletedThis study tested a new vaccine called Shigella4V2 in 110 healthy 9-month-old infants. The goal was to see if it is safe and helps the body build defenses against Shigella bacteria, which causes severe diarrhea. Researchers compared different doses to find the best one for future…
Phase: PHASE2 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 29, 2026 03:09 UTC
-
New staph vaccine shows promise in early human trial
⭐️ VACCINE ⭐️ CompletedThis early-stage study tested a new vaccine called LTB-SA7 in 129 healthy adults to see if it is safe and triggers an immune response against Staphylococcus aureus (staph) bacteria. The vaccine contains seven inactivated toxins to help the body build defenses. Results will help d…
Phase: PHASE1 • Sponsor: LimmaTech Biologics AG • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 26, 2026 20:02 UTC